OMAHA, Neb., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the results of a newly published peer-reviewed clinical study on its Thoraguard Intelligent Chest Tube Management System for use ...

OMAHA, Neb., July 26, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard® digital drainage system for cardiac surgery at Stanford University ...

• Early chest tube removal (≤3 days post-insertion) is feasible, and the rates of complications and interventions are comparable to late tube removal. • Management and timing of chest tube removal ...

Evan Luxon has been steadily focused on building medical device companies from the outset of his education and career. Luxon is an Omaha native, and earned a degree in mechanical engineering at UNL.

Please provide your email address to receive an email when new articles are posted on . Monitoring patients via a digital air leak detection device meant they spent less time with a chest tube and in ...

IRVINE, Calif.--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of ...

PleuraFlow Active Clearance Technology (ACT; ClearFlow) is a chest drain that incorporates a tube clearance system. It comprises a silicone chest tube and the PleuraFlow clearance apparatus. The ...

A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...